- Q1 2024 Abcellera Biologics Inc Earnings Call TranscriptMay 07, 2024€3.8 (+1.50%)Earnings
- Q4 2023 Abcellera Biologics Inc Earnings Call TranscriptFeb 20, 2024€4.87 (+0.04%)Earnings
- Abcellera Biologics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Abcellera Biologics Inc Earnings Call TranscriptNov 02, 2023€4.15 (+7.62%)Earnings
- Q2 2023 Abcellera Biologics Inc Earnings Call TranscriptAug 03, 2023€6.35 (-0.56%)Earnings
- Abcellera Biologics Inc at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 Abcellera Biologics Inc Earnings Call TranscriptMay 04, 2023€5.77 (-2.73%)Earnings
- Abcellera Biologics Inc at Bloom Burton & Co Healthcare Investor Conference TranscriptApr 25, 2023
- Q4 2022 Abcellera Biologics Inc Earnings Call TranscriptFeb 21, 2023€8.38 (-6.11%)Earnings
- Abcellera Biologics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Abcellera Biologics Inc at Credit Suisse Healthcare Conference TranscriptNov 09, 2022
- Q3 2022 Abcellera Biologics Inc Earnings Call TranscriptNov 08, 2022€11.92 (+0.39%)Earnings
- Q2 2022 Abcellera Biologics Inc Earnings Call TranscriptAug 09, 2022€10.79 (-6.80%)Earnings
- Q1 2022 Abcellera Biologics Inc Earnings Call TranscriptMay 10, 2022€6.43 (+2.08%)Earnings
- Abcellera Biologics Inc at Bloom Burton & Co. Healthcare Investor Conference TranscriptMay 02, 2022
- Q4 2021 Abcellera Biologics Inc Earnings Call TranscriptFeb 24, 2022€6.96 (-5.95%)Earnings
- Abcellera Biologics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- Q3 2021 Abcellera Biologics Inc Earnings Call TranscriptNov 09, 2021€12.85 (-2.65%)Earnings
- Abcellera Biologics Inc at Bank of America Tech Solutions for Drug Discovery Conference (Virtual) TranscriptSep 20, 2021
- Q2 2021 Abcellera Biologics Inc Earnings Call TranscriptAug 12, 2021Earnings
- Q1 2021 Abcellera Biologics Inc Earnings Call TranscriptMay 13, 2021Earnings
- Q4 2020 Abcellera Biologics Inc Earnings Call TranscriptMar 29, 2021Earnings
Q1 2024 Abcellera Biologics Inc Earnings Call Transcript
Good afternoon, and welcome to AbCellera's Q1 2024 business update conference call. My name is Harry, and I will facilitate the audio portion of today's interactive broadcast. (Operator Instructions)
At this time, I would like to turn the call over to Tryn Stimart, AbCellera's Chief Legal and Compliance Officer. Please go ahead.
Good morning, good afternoon, and good evening to everyone listening around the world. Thank you for joining us for Abcellera's 2024 first-quarter earnings call. I'm Tryn Stimart, Abcellera's Chief Legal and Compliance Officer.
Joining me on today's call are Dr. Carl Hansen, Abcellera's President and CEO; and Andrew Booth, Abcellera's Chief Financial Officer. During this call, we anticipate making projections and forward-looking statements based on our current expectations and pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995.
Our actual results could differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)